The occurrence of non-Hodgkin's lymphoma (NHL) is the in 2 of the 14 studied patients. p53 protein was detected in 1 of 11 lymphomas tested. LMP protein and Eber RNAs of most serious complication of Sjö gren's syndrome (SS). We performed a study of 16 NHLs occurring in patients with an Epstein-Barr virus (EBV) were not detected in the 16 NHL biopsies. Using polymerase chain reaction, EBV was never underlying SS. These lymphomas arose not only in salivary glands (7 cases) but also in other mucosal extranodal sites detected except in 1 of 4 parotid lymphomas. 
S
to play a role in the natural history of SS either as a triggering event or as a complication, 6 we looked for an association JÖ GREN'S SYNDROME (SS) is an autoimmune disease characterized by a lymphocytic infiltration of salivary and lacrimal glands leading to a progressive destruction between these NHLs and viruses such as Epstein-Barr virus (EBV), human herpes virus 8 (HHV8), hepatitis C virus of these glands and by production of autoantibodies.
1 This disorder is either isolated (primary SS) or associated with (HCV), or human T-cell lymphocytotropic virus 1 (HTLV-1). In addition, we investigated whether translocations or other systemic diseases (secondary SS). The occurrence of B-cell non-Hodgkin's lymphoma (NHL) represents the mamutations of oncogenes or antioncogenes such as bcl-2 or p53 may represent one step of the malignant transformation jor complication in the evolution of SS patients. 2 The risk of developing NHL, which is equivalent for both primary in these patients. and secondary SS, was estimated to be 44 times greater than
PATIENTS AND METHODS
that observed in a comparable normal population. 3 NHLs in SS patients occur preferentially in salivary glands and in NHL is probably a multistep process, the underlying molecuformalin or in Bouin's fixative. After being embedded in paraffin, lar events of which are still unknown. 4, 5 the sections were stained with hemotoxylin and eosin and Giemsa.
We present here the clinical, biological, histological, and The mucosal localizations were the parotid (7 cases), the Detection of the pX gene of HTLV-1 by PCR. Genomic DNA extracted from paraffin-embedded LNH sections from biopsy samlung (3 cases), the stomach (4 cases), the skin (3 cases), the ples of each patient was subjected to PCR amplification using buccal mucosa (1 case), and the thymus (1 case).
UNG. 14 were detectable in the majority of patients' sera (Table 1) patients and was associated with a type II mixed cryoglobu-
Detection of anti-p53 antibodies by enzyme-linked immunosorbent
linemia in 2 instances. Antibodies to human immunodefiassay (ELISA). Circulating anti-p53 antibodies were detected using ciency virus, HTLV-1, and HCV were not detected in paan ELISA as previously described. 22 Previous studies have shown tients' sera.
that anti-p53 antibodies are specifically found in patients with vari-
Histology, immunohistochemistry, and in situ hybridiza-
ous types of neoplasia and are not present in the normal population.
22 tion. Abbreviations: RF, rheumatoid factor; mono Ig, monoclonal Ig; hypo Ig, hypogammaglobulinemia; CR, complete remission; PR, partial remission; CLB, chlorambucil; CPM, cyclophosphamide; MTX, methotrexate; IFN, a interferon; COP, cyclophosphamide / vincristine / prednisone; CHOP, cyclophosphamide / doxorubicine / vincristine / prednisone; CVB, cyclophosphamide / vindesine / bleomycine; ACVBP, doxorubicine / cyclophosphamide / vindesine / bleomycine / prednisone; MBACOD, methotrexate / bleomycine / doxorubicine / cyclophosphamide / vincristine / dexamethasone. regardless of the tissue involved (Fig 1B) . Monocytoid cells in the last 4 cases, 1 nodal (case no. 9) and 3 extranodal, involving stomach, skin, and parotid (cases no. 2, 7, and characterized by a larger cytoplasm and a slightly irregular nucleus were mixed with centrocyte-like cells in 2 cases of 16). The gastric (case no. 2) and the skin (case no. 7) lymphomas were considered as a blastic transformation of a low-MALT lymphoma arising in the parotid (cases no. 3 and 15). There were also scattered occasional large cells grade MALT-type lymphoma because large tumoral cells were mixed with a monoclonal plasmacytic cell component (centroblast or immunoblast). In cases no. 3, 6, and 15, remnants of germinal centers with partial follicular colonization (Fig 1F) . The pathological features of these high-grade lymphomas did not differ from conventional centroblastic were observed (Fig 1C) . Beside these 9 low-grade-type mucosal lymphomas, 3 nodal lymphomas (cases no. 8, 10, and lymphoma. A high-grade diffuse large B-cell lymphoma was also subsequently diagnosed in the retroperitoneal area 10 14) had histological features similar to that of low-grade MALT type lymphoma because they showed a typical months after the initial bronchial low-grade MALT type lymphoma in 1 patient (case no. 5). Lastly, 1 patient (case lymphoplasmacytoid infiltration with a variable proportion of blasts. In 2 cases, the presence of numerous immunoblasts no. 13) with a gastric low-grade MALT-type lymphoma subsequently developed a nonepidermotropic cutaneous CD4 Tor centroblasts, mixed with small lymphoplasmacytoid cells or plasma cells, indicated an evolution to a more aggressive cell lymphoma. Aside from this latter T-cell lymphoma, the B phenotype lymphoma (Fig 1D) . The third nodal lymphoma showed a small lymphocytic or lymphoplasmacytoid diffuse infiltrate of each lymphoma was confirmed by immunoreactivity with the pan-B antibody CD20. Most specimens contained variassociated with intrasinusal large nests of monocytoid cells. This histological picture is characteristic of monocytoid Bable mixed T-cell reactive with CD3 monoclonal antibody. Monotypic Ig k light chains were noted on fixed section in cell lymphoma (MBLC; Fig 1E) .
Diffuse large B-cell lymphomas (REAL classification) 9 tested. p 53 expression was found in 1 of the 11 lymphomas tested (case no. 8). This patient had a nodal immunocytoma with approximately 10% of large cells, which were precisely the cells positive for the p53 protein.
H pylori was present in 1 of the 4 gastric lymphomas (case no. 13); EBV LMP or EBV RNAs were not detected by immunohistochemistry and hybridization techniques, respectively, in the 16 cases.
Detection of viral genes by PCR. PCR to detect EBV was performed in 12 NHL biopsies, with 4 of them being parotid samples; EBV DNA was detected in 1 parotid lymphoma (case no. 16).
The pX gene of HTLV-1 was looked for by PCR in 12 NHL biopsies but was always absent. Lip biopsies were also (14;18) share the same propensity of plasmacytic differentiation and translocation was detected in both the low-grade and the a distinctive immunological phenotype, and often exhibit a high-grade lymphoma. similar chromosomal abnormality (trisomy 3 in 50% of the Detection of anti-p53 antibodies by ELISA. p53 mutacases). 39 Furthermore, MZL can progress to high-grade large tions are known to induce an increase in the half-life of the B-cell lymphomas. 40, 41 In the light of these data, a large mutant p53, leading to the accumulation of the p53 protein number of NHLs in SS patients reported in the literature can in the tumor cells. Such accumulation can lead to a selfbe reclassified as MZL either of low-grade or of low-grade immunization process and the apparition of high levels of transformed into high-grade lymphomas. Our study provides anti-p53 antibodies in the sera of patients that harbor a muarguments in favor of this interpretation. Indeed, low-grade tant p53 in their tumor. 24 The dosage of anti-p53 antibodies MZL were diagnosed in 12 of the 16 patients, 9 of MALT is a good alternative to assess the p53 status in a tumor.
type in mucosal sites and 3 exclusively nodal. The 4 other Anti-p53 antibodies were detected at a high titer in the sera patients presented with a high-grade B-cell lymphoma that of 2 of 14 tested patients (cases no. 8 and 14; Table 2 ).
was probably a histological transformation of an underlying These 2 patients had a nodal immunocytoma and a lymlow-grade MZL at least in 3 of the cases involving skin, phoplasmacytoid lymphoma, respectively. One of these pastomach, and parotid, respectively, and in which large tutients (case no. 8) was also positive with p53 immunohistomoral cells were mixed with a monoclonal plasmacytic comchemical assay; for the other patient, no material was ponent. Lastly, T-cell lymphomas, as observed in case no. available for p53 immunohistochemical assay. 13, have been described only rarely in patients with SS. 42 In nearly half of the cases (7 cases), lymphomas arise in DISCUSSION a main target of the sicca syndrome, ie, the parotid gland. The occurrence of NHL is the most serious complication
The benign lympho-epithelial lesions characteristic of SS are of SS.
2 The risk of lymphoma in these patients reached 6.4 composed by a majority of CD4 T-cell lymphocytes 43 that cases per 1,000 per year (44 times greater than in a normal secrete interleukin 2, g-interferon, and interleukin-10 44 and population) in 136 women with SS observed for an average by a minority of B-cell lymphocytes that are often oligocloof 8.1 years.
3 Comparable results were obtained in several nal. 45, 46 A similar T-cell CD4 lymphoid hyperplasia may be reports including a small number of patients with NHL. [25] [26] [27] [28] [29] present in lacrimal glands, lungs, and kidneys of SS paNo specific histological features or unique pathogenesis tients. 47 These T cells may contribute significantly to Bcould be established in these studies. We therefore performed lymphocyte hyperactivity. 48 Aside from this characteristic Tan extensive study with clinical, histological, phenotypical, cell CD4 hyperplasia, the term pseudolymphoma has been virological, and molecular data of 16 NHL occurring in paused to coin an unusual presumably benign parotid lymphoid tients with an underlying SS.
infiltration. In the original description, 31 the infiltrate was Previous studies identified predisposing factors for the described as being composed of small lymphocytes, plasma occurrence of NHL in SS patients: parotidomegaly, splenocells, immunoblasts, and a distinct mononuclear cell populamegaly, lymphadenopathy, low-dose parotid irradiation, cytion that most likely represents monocytoid B lymphocytes. totoxic therapy, 3 the presence of a serum or urinary monoThus, what was called pseudolymphoma in the literature clonal component 30 or mixed cryoglobulinemia, 29 and a corresponds probably in most cases to slowly progressive decrease in serum polyclonal Igs. 31 Our study was not a MALT/MBCL. The possibility that detection of clonal B prospective analysis of SS patients and, therefore, we could cells by PCR may help to distinguish MALT/MBCL from not establish definite conclusions on the value of these prebenign lympho-epithelial lesions remains controversial. In disposing factors. However, a history of parotid enlargement one study, 14 of 14 (100%) labial salivary gland (LSG) and irradiation was present in 1 patient and previous cytospecimens of SS patients exhibited oligoclonal or monotoxic therapy had been administered in 4 patients (prednisone clonal Ig gene rearrangements by PCR 45 ; in 1 patient with in 3 cases, methotrexate in 1 case, and azathioprine in 1 lymphoma, tumor and LSG specimens obtained at the same case). Three patients had a serum monoclonal Ig, 2 of them time displayed different Ig gene rearrangements. However, having a mixed type II cryoglobulin and 2 others having a in another study, monoclonal B cells were detected by PCR decrease in serum polyclonal Igs occurring at the time of in only 11 of 76 (15%) LSG specimens of SS patients 49 ; 4 lymphoma diagnosis.
of these 11 patients subsequently developed extrasalivary Various histological subtypes of NHL have been described lymphoma and in each case the rearranged bands in the lip in the literature of patients with SS: Waldenström's macrobiopsy and the lymphoma were of the same size. Likewise, globulinemia, 31 immunocytomas, 27 follicular lymphomas, 32 in another study, the use of a VH CDR3 allele-specific probe diffuse large B-cell lymphomas, 3 immunoblastic lymphoshowed that benign lymphoepithelial lesions of stomach and mas, 33 and especially MALT lymphomas. 34 The recent desalivary glands present 13 and 2 years, respectively, before scription of monocytoid B-cell lymphomas (MBCL), [35] [36] [37] the onset of a gastric lymphoma contained B cells with a which appears as the nodal counterpart of MALT lymphorearranged heavy chain identical to that found in the late mas 38 The data given above suggest that the development of that methotrexate might have a role in the development of the lymphoma of this patient because it had none of the lymphoma in SS involves a multistep process, possibly the sequential activation of proto-oncogenes by translocations above-mentioned characteristics of methotrexate-associated lymphomas. or mutations and/or viral infection. Using a PCR detecting translocations focused in the major breakpoint region, 51 we Recently, another herpes virus termed HHV8 has been found to be associated not only with Kaposi's sarcoma 18 but detected a t(14;18) translocation in 1 of 8 lymphomas tested. Interestingly, this patient had a bronchial MALT lymphoma also with body cavity lymphomas, Castleman disease, and some lymphoid hyperplasia occurring in autoimmune disthat progressed 10 months later into a nodal large B-cell lymphoma. The t(14;18) translocation was detected in both eases. 59 Therefore, we looked for HHV8 by PCR in SSassociated lymphomas. However, this study was negative. the low-grade and the high-grade lymphoma. The t(14;18) translocation is usually not present in MZL. 39 However, it None of our patients had HCV infection, which may be associated with some sicca syndrome 60 and in some countries was already detected by two groups in a subset of Sjögren's lymphomas. 26, 52 Pisa et al 26 found the t(14;18) translocation with lymphomas. 61 Lastly, because the pX gene of the retrovirus HTLV-1 has been detected in labial salivary glands in 5 of 7 SS-associated salivary lymphomas. It was not present, either in prelymphoma biopsies from these patients, even from some Japanese and French SS patients seronegative for HTLV-1, 17, 62 we looked for the presence of this gene in SSthough they exhibited oligoclonal B-cell rearrangements, or in 50 salivary gland biopsies of SS patients. We studied the associated lymphomas, but it was not detectable by PCR. Three of the 16 SS patients with lymphoma were also tested expression of the bcl-2 protein in the 16 lymphoma specimens. The bcl-2 protein was expressed in 14 of these 16 for the presence of HTLV-1 pX sequences in LSG. One of them was positive; however, the gastric lymphoma of this lymphomas, as expected in low-grade MZL, which are usually considered to overexpress the bcl-2 protein 53 without patient did not contain the pX sequence.
In conclusion, lymphomas occurring in patients with an rearrangement of the bcl-2 gene. 39 Mutations of the tumor-suppressor activity gene p53 have underlying SS are in most cases MZL. Chemotherapy is usually efficient and long-term survival in CR or PR is combeen observed in lymphomas and have been associated with progression of low-grade MALT lymphoma to high-grade. 54 mon in these patients. These lymphomas are not associated with viruses known to be present in other types of lymphoThis inactivation of p53 activity is accompanied by an overexpression of the p53 protein and in half of the cases by mas. Some of the translocations or mutations of oncogenes or antioncogenes described in other lymphomas are detected detection of serum anti-p53 antibodies. 24 We detected serum anti-p53 antibodies in 2 of the 14 patients studied (cases no.
in SS-associated lymphomas. However, we could not detect a recurrent molecular abnormality that could have given new 8 and 14); these 2 patients had a nodal MZL. One of these 2 patients could be tested with p53 immunohistochemically insights into a common pathogenesis for these lymphomas. assay and was positive in a small component of large cells We also looked for the presence of viruses in these assistance. lymphomas because they have been implicated in the etiology of some sicca syndromes. 6 We focused on the potential AID Blood 0021 / 5h39$$$401 06-23-97 17:24:32 blda WBS: Blood
